4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-032725
Chief Financial Officer gave up 228 shares (to pay taxes)
- Chief Financial Officer acquired 464 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mokari Atabak Chief Financial Officer | 2025-03-03 | Shares withheld for taxes | −228 | $60.58 | $13,812 | 12,570 | D: show line 1 in the form |
| Mokari Atabak Chief Financial Officer | 2025-03-03 | Grant or award | +232 | $59.07 | $13,704 | 12,802 | D: show line 2 in the form |
| Mokari Atabak Chief Financial Officer | 2025-03-03 | Grant or award | +232 | 13,034 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Mokari Atabak Chief Financial Officer | 2025-02-28 | Grant or award · Stock option (right to buy) | +140,000 | 140,000 | D: show line 4 in the form |
Loading xslF345X05/ownership.xml…